34
C. Zhao et al. / Journal of Catalysis 250 (2007) 33–40
demonstrating that an optimum balance between stability and
reactivity to be a critical parameter.
2.1.2. Synthesis of 1-vinyl-3-ethylimidazolium bromide
([VEIM]Br)
The hydrogenation of benzene and arenes, which is ac-
complished using heterogeneous catalysts almost exclusively
[13,14], molecular precatalysts immobilized on heterogeneous
surfaces [15–17], supported nanoparticle [18], or soluble nano-
particle [19,20] systems, sometimes inadvertently derived from
molecular precursors [21,22], represents an important indus-
trial catalytic transformation, particularly for the production of
cleaner-burning, low-aromatic diesel fuels [13]. The partial hy-
drogenation of arenas, which is far more difficult to realize, is
equally important because it can help to simplify many mul-
tistage synthetic procedures and allow the use of alternative
precursors [23]. The catalytic procedure for partial hydrogena-
tion of arenes generally is not simple; for example, the selective
hydrogenation of benzene to cyclohexene performed on an in-
dustrial scale involves a multiphase process using a ruthenium-
based heterogeneous catalyst, which results in 90% conversion
and 60% selectivity [24].
In an extension to our preliminary report on Rh nanoparticles
that catalyze the hydrogenation of benzene in ILs with unprece-
dented lifetimes [12], we now describe their application to the
hydrogenation of benzene and other arenes in greater detail. IL-
like copolymers were evaluated in terms of composition and
average molecular weight and compared with poly(N-vinyl-2-
pyrrolidone) (PVP), a widely used protecting agent [9,25]. The
hydrogenation of arene substrates with various alkyl and other
substituents was then investigated, and activities were corre-
lated to nanoparticle structure. Moreover, we found that these
rhodium nanoparticles are highly active catalysts for the partial
hydrogenation of arene substrates in ILs, with very high selec-
tivity toward the monoene in some cases.
1-Vinylimidazole (5.00 g, 53 mmol) was mixed with ethyl
bromide (6.54 g, 60 mmol), and the mixture was stirred vigor-
ously at 70
◦C for 3 h. After reaction, the ethyl bromide was
removed under vacuum at 60 ◦C for 2 h to afford a pale-yellow
solid [VEIM]Br. Yield 9.80 g, 95%.
1H NMR δ (300 MHz, D2O) 1.35 (t, J = 7.6, 3H, CH3),
4.10 (q, J = 7.6, 2H, CH2), 5.24 (dd, J = 8.6, 2.4, 2H, CH2),
5.62 (dd, J = 15.2, 2.4, 1H, CH), 6.96 (dd, J = 15.2, 8.6, 1H,
CH), 7.30 (s, 1H, NH), 7.59 (s, 1H, NH).
13C NMR δ (75 MHz, D2O) 16.61, 47.50, 111.44, 113.01,
121.66, 124.81, 130.57 ppm.
Anal. Calcd. for C7H11N2Br: C, 41.40; H, 5.46; N, 13.79.
Found: C, 41.47; H, 5.55; N, 13.95.
HRMS Calcd. for C7H11N+2 : 123.0917. Found: 123.0915.
2.1.3. Copolymerization
A mixture of N-vinyl-2-pyrrolidone (NVP) (0.5 g, 4.5
mmol), [VBIM]Cl (0.43 g, 2.3 mmol) or [VEIM]Br (0.46 g,
2.3 mmol), and 2,2ꢀ-azo-bis-isobutyronitrile (AIBN) (6.9 mg,
0.042 mmol) in methanol (5 ml, degassed by 3 freeze/thaw cy-
cles) was stirred in a preheated oil bath at 60 ◦C for 16 h. The
resulting solid was dissolved in methanol (5 ml) and precipi-
tated in diethyl ether (500 ml). The residual monomers were
removed by dialysis in distilled water for 24 h, and the solvent
was removed under reduced pressure. Finally, the copolymers
were dried under vacuum at room temperature. Yield ∼0.8 g.
2.2. Preparation of Rh nanoparticles in ILs
Rhodium nanoparticles were prepared by reduction of RhCl3
(1.6 × 10−5 mol) with H2 in 1-butyl-3-methylimidazolium
tetrafluoroborate ([BMIM][BF4]) (6 ml) containing poly(NVP-
co-VBIMCl) ([poly(NVP-co-VBIMCl)]/[Rh] = 5:1). Typically,
the preparation was carried out in a 100 ml autoclave to afford
a black solution after reduction at 60 ◦C and H2 (40 bar) for
30 min.
2. Experimental
2.1. Synthesis of copolymers
2.1.1. Synthesis of 1-vinyl-3-butylimidazolium chloride
([VBIM]Cl)
2.3. Arene hydrogenation reactions
1-Vinylimidazole (5.00 g, 53 mmol) and butyl chloride
(18.50 g, 200 mmol) were mixed and stirred vigorously at 70 ◦C
for 24 h. The residual mixture was cooled to 0 ◦C, and then
the upper liquid layer was removed by decantation. The residue
was then washed with ethyl acetate (3 × 30 ml), evaporated un-
der vacuum, and dried to yield a pale-yellow solid [VBIM]Cl
(7.74 g, 75%).
The arene (32 mmol) and Rh nanoparticle solution (6 ml,
synthesized as described above) were placed in the autoclave. In
a typical experiment, H2 (40 bar) was introduced into the auto-
clave after the reactor was purged 3 times with H2. The mixture
was stirred at 800 rpm at 75 ◦C for 10 h, which afforded a two-
phase system (the lower IL phase-containing catalysts and the
upper organic phase). The upper layer was decanted and ana-
lyzed by GC, GC–MS, IR, and 1H NMR spectroscopy.
1H NMR δ (300 MHz, D2O) 0.98 (t, J = 7.6, 3H, CH3),
1.41 (m, 2H, CH2), 1.95 (m, 2H, CH2), 4.41 (t, J = 7.6, 2H,
CH2), 5.39 (dd, J = 8.7, 3.0, 1H, CH), 6.01 (dd, J = 14.7, 2.7,
1H, CH), 7.55 (dd, J = 14.7, 8.7, 2H, CH2), 7.88 (s, 1H, NH),
11.35 (s, 1H, NH) ppm.
2.4. Mercury poisoning experiments
13C NMR δ (75 MHz, D2O) 13.40, 19.41, 32.00, 50.06,
101.82, 118.92, 122.35, 128.41, 136.87 ppm.
2.4.1. Experiment 1. Hydrogenation without mercury
Anal. Calcd. for C9H15N2Cl: C, 57.90; H, 8.10; N, 15.01.
Found: C, 57.81; H, 8.02; N, 15.10.
To a solution of [BMIM][BF4] (6 ml) containing Rh nano-
particles (0.016 mmol Rh) and poly(NVP-co-VBIMCl)
(0.08 mmol), benzene (2.5 g, 32 mmol) was added in a 100 ml
HRMS Calcd. for C9H15N+2 : 151.1230. Found: 151.1227.